Michael H. Wilson

Array ( [id] => 7055932 [patent_doc_number] => 20050277106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Methods and active substances for protecting organs' [patent_app_type] => utility [patent_app_number] => 11/165925 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6467 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277106.pdf [firstpage_image] =>[orig_patent_app_number] => 11165925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 460467 [patent_doc_number] => 07241871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => 'Method and process for the production of collagen preparations from invertebrate marine animals and compositions thereof' [patent_app_type] => utility [patent_app_number] => 11/159677 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8553 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241871.pdf [firstpage_image] =>[orig_patent_app_number] => 11159677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 296060 [patent_doc_number] => 07541330 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Conjugates with reduced adverse systemic effects' [patent_app_type] => utility [patent_app_number] => 11/149758 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8307 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541330.pdf [firstpage_image] =>[orig_patent_app_number] => 11149758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6953076 [patent_doc_number] => 20050228171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Purification method' [patent_app_type] => utility [patent_app_number] => 11/146835 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8088 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20050228171.pdf [firstpage_image] =>[orig_patent_app_number] => 11146835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966001 [patent_doc_number] => 20050232898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Stabilized protein compositions' [patent_app_type] => utility [patent_app_number] => 11/143340 [patent_app_country] => US [patent_app_date] => 2005-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13968 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232898.pdf [firstpage_image] =>[orig_patent_app_number] => 11143340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 170758 [patent_doc_number] => 07662777 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Use of sulglicotide for the treatment of mucositis' [patent_app_type] => utility [patent_app_number] => 11/569095 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2155 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662777.pdf [firstpage_image] =>[orig_patent_app_number] => 11569095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307452 [patent_doc_number] => 07531518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Method for fostering bone formation and preservation' [patent_app_type] => utility [patent_app_number] => 11/128095 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8174 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531518.pdf [firstpage_image] =>[orig_patent_app_number] => 11128095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7046086 [patent_doc_number] => 20050250681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Treatment of ocular diseases and disorders using lantibiotic compositions' [patent_app_type] => utility [patent_app_number] => 11/123436 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13812 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250681.pdf [firstpage_image] =>[orig_patent_app_number] => 11123436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057591 [patent_doc_number] => 20070060513 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2007-03-15 [patent_title] => 'Method for increasing the serum half-life of a biologically active molecule' [patent_app_type] => utility [patent_app_number] => 11/113592 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6599 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0060/20070060513.pdf [firstpage_image] =>[orig_patent_app_number] => 11113592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057591 [patent_doc_number] => 20070060513 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2007-03-15 [patent_title] => 'Method for increasing the serum half-life of a biologically active molecule' [patent_app_type] => utility [patent_app_number] => 11/113592 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6599 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0060/20070060513.pdf [firstpage_image] =>[orig_patent_app_number] => 11113592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945247 [patent_doc_number] => 20050197296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Agents for preventing and treating thrombocytopenia' [patent_app_type] => utility [patent_app_number] => 11/110852 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3206 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197296.pdf [firstpage_image] =>[orig_patent_app_number] => 11110852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738983 [patent_doc_number] => 20060009374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Antibacterial peptide' [patent_app_type] => utility [patent_app_number] => 11/093875 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10847 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009374.pdf [firstpage_image] =>[orig_patent_app_number] => 11093875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217253 [patent_doc_number] => 07612163 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-11-03 [patent_title] => 'Prokineticin 2β peptide and its use' [patent_app_type] => utility [patent_app_number] => 10/594832 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 7698 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612163.pdf [firstpage_image] =>[orig_patent_app_number] => 10594832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216230 [patent_doc_number] => 20050260140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Mucolytic and anti-elastase compounds and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/090916 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 33488 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260140.pdf [firstpage_image] =>[orig_patent_app_number] => 11090916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111985 [patent_doc_number] => 20050209441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Process for promoting proper folding of human serum albumin using a human serum albumin ligand' [patent_app_type] => utility [patent_app_number] => 11/085291 [patent_app_country] => US [patent_app_date] => 2005-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9548 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209441.pdf [firstpage_image] =>[orig_patent_app_number] => 11085291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957881 [patent_doc_number] => 20050214251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Rapid acting drug delivery compositions' [patent_app_type] => utility [patent_app_number] => 11/077604 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8405 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214251.pdf [firstpage_image] =>[orig_patent_app_number] => 11077604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967068 [patent_doc_number] => 20050233965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Method of inhibiting vascular permeability' [patent_app_type] => utility [patent_app_number] => 11/054789 [patent_app_country] => US [patent_app_date] => 2005-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19183 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233965.pdf [firstpage_image] =>[orig_patent_app_number] => 11054789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 457030 [patent_doc_number] => 07244828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'Agent for protein precipitation, a method of protein precipitation, a method of protein assay using protein precipitation agent, and a kit for protein assay' [patent_app_type] => utility [patent_app_number] => 11/048892 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 11035 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244828.pdf [firstpage_image] =>[orig_patent_app_number] => 11048892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960553 [patent_doc_number] => 20080274978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Peptides That Antagonize Fpr Class Receptor Mediated Signaling' [patent_app_type] => utility [patent_app_number] => 10/597591 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15417 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274978.pdf [firstpage_image] =>[orig_patent_app_number] => 10597591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856822 [patent_doc_number] => 07375081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Therapeutic combination of a pneumocandin derivative and an antifungal agent' [patent_app_type] => utility [patent_app_number] => 11/038155 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2810 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375081.pdf [firstpage_image] =>[orig_patent_app_number] => 11038155 [rel_patent_id] =>[rel_patent_doc_number] =>)